Scott Evans
7Patents
2h-index
8Co-inventors
40Inventor score
Filing activity: Mar 25, 2010 → Jul 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8883174B2 | Compositions for stimulation of mammalian innate immune resistance to pathogens | Emerging Cross-Sectional Technologies | 7 | Active |
| US9186400B2 | Compositions for stimulation of mammalian innate immune resistance to pathogens | Emerging Cross-Sectional Technologies | 4 | Active |
| US10286065B2 | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds | Emerging Cross-Sectional Technologies | 1 | Active |
| US11826422B2 | Methods and compositions for adaptive immune modulation | Chemistry; Metallurgy | 0 | Active |
| US10722573B2 | Compositions for stimulation of mammalian innate immune resistance to pathogens | Emerging Cross-Sectional Technologies | 0 | Active |
| US12201684B2 | Compositions for stimulation of mammalian innate immune resistance to pathogens | Emerging Cross-Sectional Technologies | 0 | Active |
| US9504742B2 | Compositions for stimulation of mammalian innate immune resistance to pathogens | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.